Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Use
Invivoscribe, Inc., a technology-driven international company focused on precision diagnostics with best-in-class products and services that optimize patient care and accelerate drug approvals worldwide, today announced licensing of key software and two new MRD clinical services.
“Clinical labs need to be able to analyze large amounts of clonality and MRD data quickly and easily. Current bioinformatics software generally requires that technicians click through software to analyze data one patient at a time; this is both tedious and prone to human errors. With such a large volume of patients samples we need to get from data to report as easily and accurately as possible,” says Dr. Sean Glenn of Roswell Park Comprehensive Cancer Center, New York.
Invivoscribe’s new pipeline LymphoTrack® Enterprise Software enables high volume customers to meet ever increasing testing demands. Laboratories require a high throughput platform that is both compliant with HIPAA requirements and provides seamless visualization to help interpret the raw data. They also want to be able to mine data from antigen receptor CDR3 regions. We’ve addressed both of these needs with the new pipeline software. The pipeline software for LymphoTrack on MiSeq® is available now with raw data access, CDR3 mining and reporting capabilities.
Tony Lialin, Chief Commercial Officer at Invivoscribe shared, “Software has been a hugely undervalued asset at Invivoscribe. We have developed tools for internal use that our customers would love to have access to in order to streamline their workflow and reduce bottlenecks in testing. This is a bioinformatics package we can commercialize to help support our partners, so we are doing just that.”
The new B-cell MRD Clonality and MyMRD-Myeloid Assays will be offered as LabPMM services using Illumina’s NextSeq® 550Dx and/or NovaSeq®. The release of these clinical services will rapidly follow the release of the LymphoTrack Enterprise Software. The new MRD services will be available for research studies in late 2021 and are slated for CAP/CLIA accreditation in early 2022.
With internationally standardized kits and services, custom assay development solutions, clinical trial management, regulatory expertise, and most recently, expanding availability and support for our bioinformatics analysis software, Invivoscribe continues to innovate to provide comprehensive support to our global partners.
About Invivoscribe
Invivoscribe has been Improving Lives with Precision Diagnostics® for more than twenty-five years, advancing the field of precision medicine by developing and selling standardized reagents, tests, and bioinformatics tools to more than 700 customers in 160 countries. Invivoscribe also has a significant impact on global health working with pharmaceutical companies to accelerate approvals of new drugs and treatments by supporting international clinical trials, developing, commercializing companion diagnostics, and providing expertise in both regulatory and laboratory services. With its proven ability to provide global access to distributable reagents, kits, and controls, as well as clinical trial services through our international clinical lab subsidiaries (LabPMM), Invivoscribe has demonstrated it is an ideal partner. For additional information please visit: www.invivoscribe.com or contact Invivoscribe at: customerservice@invivoscribe.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210902005220/en/
Contact information
Tony Lialin
inquiry@invivoscribe.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
‘Hidden Gem’ Arrives in Rotterdam to be Transformed into Nodule Collection Vessel for The Metals Company21.9.2021 19:37:00 EEST | Press release
The Metals Company (Nasdaq: TMC) today announced that the 228-meter-long former drill ship renamed the Hidden Gem has arrived in Rotterdam, The Netherlands to begin its conversion into what is expected to be the first ship classified as a sub-sea mining vessel by the American Bureau of Shipping. TMC’s strategic partner Allseas acquired the former ultra-deep-water drill ship, which can accommodate 200 people, in March of 2020, as her configuration is well-suited for modifications that will enable the deployment at sea of a 4.5 kilometer-long riser to bring polymetallic nodules up from the seafloor. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005945/en/ Hidden Gem vessel (Photo: Business Wire) In partnership with The Metals Company (formerly DeepGreen Metals Inc.), Allseas is developing a deep-sea mineral collection system to responsibly recover polymetallic nodules from the ocean floor and transfer them to the surfac
Rhizen Pharmaceuticals AG Announces First Patient Dosed in a Phase 2 Study of RP7214 in Covid-19 Patients21.9.2021 19:36:00 EEST | Press release
Rhizen Pharmaceuticals AG, a clinical-stage oncology & inflammation-focussed biopharmaceutical company, today announced that the first patient has been dosed in a Phase 2 clinical trial of RP7214, a small molecule oral dihydroorotate dehydrogenase (DHODH) Inhibitor. The randomized, double-blind, placebo-controlled, Phase 2 study will evaluate the efficacy & safety of oral RP7214, in covid-19 patients with mild, symptomatic disease with an underlying risk factor on the background of promising preclinical efficacy & phase 1 healthy volunteer safety. The study is being conducted in India across 12 centres in coordination with Rhizen’s India affiliate, Incozen Therapeutics Pvt ltd., and is designed to enrol up to 204 patients across both study arms. Viral replication involves a huge demand for building blocks and relies on nucleotides derived from host cells. DHODH is a rate-limiting enzyme in the pyrimidine biosynthesis pathway, inhibition of which leads to depletion of host nucleotide po
Citi Private Bank Finds Cautious Optimism Among Investors for 2022 with Covid-19, Inflation and Peak Market Valuations Top of Mind21.9.2021 19:31:00 EEST | Press release
Citi Private Bank’s Private Capital Group today released the results of its 2021 Family Office Survey, compiling the unique perspectives and insights of many of the world’s sophisticated family offices and ultra-high net worth investors in a challenging climate. This year’s survey included nearly 200 responses, an 11% increase from 2020. Four predominant themes emerged: 1) concern on rising inflation, 2) the prominence of high cash levels in the face of low yield environment, 3) continued growth in portfolio allocation to direct investing opportunities, and 4) a marked comeback in portfolio values year over year despite prevalent degree of macroeconomic uncertainty. While over three-fourths of all respondents seek returns of 5% or more over the next 12 months, the outlook is more optimistic for family offices with AUM over $500 million with 30% seeking over 10% returns versus 19% of family offices with AUM under $500 million. This likely factors in the additional institutional tools an
SSIMWAVE Selects Verimatrix Code Protection to Prevent Reverse Engineering of its Award-Winning Video Experience Platform21.9.2021 18:45:00 EEST | Press release
Regulatory News: Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Ontario, Canada-based SSIMWAVE Inc. is one of its latest customers to integrate Verimatrix Code Protection technology. IP theft is a growing threat to organizations worldwide. The Commission on the Theft of American Intellectual Property estimates that costs from IP losses are as high as $600 billion annually. “Verimatrix has a lengthy and successful history in the media and entertainment space, so it made sense to turn to their code protection technologies,” said Peter Olijnyk, Vice President of Engineering at SSIMWAVE. “When you’re protecting the core foundation of your platform, Verimatrix’s transparent and timely process for getting up and running – not to mention in about a day or so – was reassuring and provides peace of mind for SSIMWAVE and our customers.” A video quality innovator, SSIMWAVE evaluated numerous vendors and deci
Latest Report From Arthur D. Little Brings New Perspectives on Mobility-as-a-Service (MaaS)21.9.2021 18:22:00 EEST | Press release
Arthur D. Little (ADL) today released a new report on the current state of the global Mobility-as-a-Service (MaaS) market. Entitled ‘How To Realize The Promise Of Mobility-as-a-Service’, this study is released by the company’s Future Of Mobility Lab. While much has been written over the past few years about MaaS and its vision of revolutionizing transport in the modern city, much of the current discourse has been either academic or conceptual, envisaging ambitious futures built on fragile foundations. With this study, ADL aims to offer a more objective view of the subject, based on the company’s wide-ranging consultation with both public and private actors, and its assessment of the successes and failures of real world MaaS deployments. The study identifies five key factors for achieving a successful MaaS deployment. These are: Recognizing that MaaS is more than just an app, but should be part of a broader mobility vision requiring the development of integrated mobility policies, physi
project44 Buys Last-Mile Delivery and Customer Experience Leader, Convey, in $255M Acquisition21.9.2021 17:00:00 EEST | Press release
project44, the global leader in real-time supply chain visibility, today announced that it has acquired Austin-based Convey, the last-mile technology leader that powers exceptional direct-to-consumer delivery experiences for more than 200 of the world’s largest brands, including The Home Depot, Nieman Marcus, Ferguson, Ingram-Micro, and others. Convey, recognized as a Challenger in the Gartner 2021 Magic Quadrant for Real-Time Visibility Platforms, combines real-time visibility, post-purchase experiences, and machine learning-powered analytics to improve the overall customer experience. Together, the two companies now serve the global supply chain end-to-end, providing real-time visibility and actionable insights from raw materials to the front door to help brands deliver differentiated direct-to-consumer and eCommerce experiences for their customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005205/en/ project44
Andersen Global Continues Asian Expansion With Malaysian-Based Law Firm21.9.2021 16:30:00 EEST | Press release
Andersen Global continues its expansion in Asia through a Collaboration Agreement with Malaysian-based law firm Halim Hong & Quek Advocates & Solicitors (HHQ). Founded in 2000, HHQ offers full-service legal capabilities in alternative dispute resolution, banking and finance, corporate and M&A, energy and infrastructure, litigation, real estate and construction. With offices in Kuala Lumpur, Johor and Penang, the firm provides services to a wide range of domestic and international companies as well as high net worth individuals and foreign investors. “Our goal is to empower individuals and businesses with best-in-class legal services while creating a value-added social impact through our capabilities,” Managing Partner Dato’ Quek Ngee Meng. “We hire those who strive for the best and possess a positive mindset. Our team is dedicated to investing in our people to bring exceptional service and solutions to our clients. Collaborating with Andersen Global expands our platform and ability to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom